technicals, page-23

thanks for jogging the memory regards ATL1102 what was most interesting as well is that ATL1102 has passed a phase 11 safety efficacy trial already and like as stated regarding antisense drugs because they all work very similar meaning they just change different strands of the RNA (is that right please correct me if I have it wrong here) thus boding well for the safety and efficacy of ATL1103. Well thats my take on it so really exciting stuff that the drugs are so closely related that they can sometimes predict in advance what could happen based on other similar drugs so for me this is a BIG thumbs up so thanks again for the reminder all IMO